- Home
- LNTH vs ALE Comparison
LNTH vs ALE Comparison
Compare LNTH & ALE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LNTH | ALE |
|---|---|---|
| Founded | 1956 | 1906 |
| Country | United States | United States |
| Employees | 808 | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Power Generation |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.2B | 3.8B |
| IPO Year | 2015 | N/A |
Fundamental Metrics
Financial Performance| Metric | LNTH | ALE |
|---|---|---|
| Price | $63.42 | $67.62 |
| Analyst Decision | Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $74.17 | N/A |
| AVG Volume (30 Days) | ★ 1.1M | 652.3K |
| Earning Date | 11-06-2025 | 10-31-2025 |
| Dividend Yield | N/A | ★ 4.32% |
| EPS Growth | N/A | ★ N/A |
| EPS | 2.39 | ★ 2.85 |
| Revenue | ★ $1,525,933,000.00 | $1,500,300,000.00 |
| Revenue This Year | $0.01 | $2.24 |
| Revenue Next Year | $1.24 | $5.63 |
| P/E Ratio | $26.45 | ★ $23.73 |
| Revenue Growth | ★ 1.95 | N/A |
| 52 Week Low | $47.25 | $62.38 |
| 52 Week High | $111.29 | $67.71 |
Technical Indicators
Market Signals| Indicator | LNTH | ALE |
|---|---|---|
| Relative Strength Index (RSI) | 71.16 | 62.92 |
| Support Level | $57.44 | $67.35 |
| Resistance Level | $59.30 | $67.71 |
| Average True Range (ATR) | 2.14 | 0.12 |
| MACD | 0.82 | -0.02 |
| Stochastic Oscillator | 91.35 | 72.31 |
Price Performance
Historical ComparisonAbout LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
About ALE Allete Inc.
ALLETE Inc provides competitively-priced energy in America's Upper Midwest region and invests in transmission infrastructure and other energy-centric businesses. The company has two reportable segments. The first segment is Regulated Operations, which includes the company's regulated utilities, Minnesota Power and SWL&P, as well as its investment in ATC. ATC is a regulated utility based in Wisconsin that owns and maintains electric transmission assets in parts of Wisconsin, Michigan, Minnesota, and Illinois. The second segment is ALLETE Clean Energy, which focuses on developing, acquiring, and operating clean and renewable energy projects.